# Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition

> **NCT01831687** · PHASE1 · COMPLETED · sponsor: **IPCA Laboratories Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Fasting

## Interventions

- **DRUG:** Etodolac Extended Release Tablets USP 600mg
- **DRUG:** Etodolac Extended Release Tablets 600mg

## Key facts

- **NCT ID:** NCT01831687
- **Lead sponsor:** IPCA Laboratories Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2013-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01831687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01831687, "Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01831687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*